Back to Search
SABRI SEN, M.D.
M.D.
Urology Physician
NPI: 1720043862Individual
Specialties, Licenses & Credentials
Clinical Trials (4)
4
Linked Trials
1
Recruiting
3
With Results
Effect of Empagliflozin on Podocyte Specific Proteins in African American Veterans With NDKD
NCT06110130RECRUITINGPHASE4PRINCIPAL_INVESTIGATOR
Linagliptin's Effect on CD34+ Stem Cells
NCT02467478COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Role of Canagliflozin on CD34+ Cells in Patients With Type 2 Diabetes
NCT02964585COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Effect of Saxagliptin on EPCs as a Cellular Biomarker for Evaluating Endothelial Dysfunction in Early T2DM Patients
NCT02024477COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (20)
Role of Canagliflozin on function of CD34+ve endothelial progenitor cells (EPC) in patients with type 2 diabetes.
PMID 33581737·Cardiovasc Diabetol·2021
3-trial
Linagliptin, when compared to placebo, improves CD34+ve endothelial progenitor cells in type 2 diabetes subjects with chronic kidney disease taking metformin and/or insulin: a randomized controlled trial.
PMID 32493344·Cardiovasc Diabetol·2020
3-trial
The synergistic effects of saxagliptin and metformin on CD34+ endothelial progenitor cells in early type 2 diabetes patients: a randomized clinical trial.
PMID 29724198·Cardiovasc Diabetol·2018
3-trial
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
PMID 26378978·N Engl J Med·2015
4-observational
Sodium glucose transport 2 (SGLT2) inhibition decreases glomerular hyperfiltration: is there a role for SGLT2 inhibitors in diabetic kidney disease?
PMID 24334174·Circulation·2014
8-other
Blood pressure effects of sodium-glucose co-transport 2 (SGLT2) inhibitors.
PMID 24631482·J Am Soc Hypertens·2014
6-review
Kidney disease and increased mortality risk in type 2 diabetes.
PMID 23362314·J Am Soc Nephrol·2013
8-other
Endothelial progenitor cell dysfunction in patients with progressive chronic kidney disease.
PMID 19339628·Am J Physiol Renal Physiol·2009
8-other
Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial.
PMID 17562958·Circulation·2007
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 4053 LONE TREE WAY STE 200
ANTIOCH, CA 94531 - Phone
- (925) 776-7725
Quick Facts
- NPI
- 1720043862
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 3
- Clinical Trials
- 4
- Publications
- 20
Are you this provider?
Claim Your Profile